ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,501, issued on July 1, was assigned to INSULET Corp. (Acton, Mass.).
"Techniques to reduce risk of occlusions in drug delivery systems" was invented by Yibin Zheng (Hartland, Wis.), Joon Bok Lee (Acton, Mass.) and Jason O'Connor (Acton, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are techniques to establish a modified pump rate that mitigates the effects of a pump occlusion and enables a recommended dosage of insulin to be output by a pump mechanism over the course of a control cycle. In an example, the pump rate may be reduced by adding a calculated time interval between application of actuation commands to extend the amount of ti...